CANCELLED - SECTION 8
section 8
on 11 Aug 2017
Last Applicant/ Owned by
204-407 Downey Road
Saskatoon
CA
Serial Number
77107110 filed on 14th Feb 2007
Registration Number
3898353 registered on 04th Jan 2011
Correspondent Address
Daniel A. Rosenberg
Filing Basis
No Filing Basis
Disclaimer
"PHARMA"
PHREEDOM PHARMA
Chemical preparations for treating chronic debilitating diseases in humans, namely, cancer, neurodegenerative disorders and rheumatoid arthritis; Pharmaceutical preparations for use in treatment of chronic debilitating diseases in humans, namely, cancer, neurodegenerative disorders and rheumatoid arthritis FREEDOM PHARMACEUTICAL "PHARMA" Product research and development in the filed of chemical Read More
Classification Information
Class [005]
Pharmaceutical Products
Chemical preparations for treating chronic debilitating diseases in humans, namely, cancer, neurodegenerative disorders and rheumatoid arthritis; Pharmaceutical preparations for use in treatment of chronic debilitating diseases in humans, namely, cancer, neurodegenerative disorders and rheumatoid arthritis
Class [042]
Computer & Software Services & Scientific Services
Product research and development in the filed of chemicals, pharmaceutical preparations, vitamin preparations, and supplements for human use, but not for retail drug store or retail pharmacy services
Mark Details
Serial Number
No 77107110
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Aug 2017 | CANCELLED SEC. 8 (6-YR) |
| 04th Jan 2011 | REGISTERED-PRINCIPAL REGISTER |
| 19th Oct 2010 | PUBLISHED FOR OPPOSITION |
| 19th Oct 2010 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 15th Sep 2010 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 14th Sep 2010 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 14th Sep 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 14th Sep 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 14th Sep 2010 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 31st Aug 2010 | PRIORITY ACTION E-MAILED |